Skip to main content
Premium Trial:

Request an Annual Quote

CloudLIMS Lite

CloudLIMS has released a new version of its pay-as-you-go LIMS, CloudLIMS Lite, to help biobanks and clinical, research, and testing laboratories keep track of their biospecimens and testing workflows. The new version is more efficient in facilitating testing and reporting of multiple analytes, the company said. The software can create analyte groups for each test and configure one or more analytes under a group; specify range for every analyte and create flagging sets such as high, low, critical high, critical low, et cetera, to flag test results based on obtained values; and publish test reports containing multiple analytes, among other functionalities.

The Scan

Another Resignation

According to the Wall Street Journal, a third advisory panel member has resigned following the US Food and Drug Administration's approval of an Alzheimer's disease drug.

Novavax Finds Its Vaccine Effective

Reuters reports Novavax's SARS-CoV-2 vaccine is more than 90 percent effective in preventing COVID-19.

Can't Be Used

The US Food and Drug Administration says millions of vaccine doses made at an embattled manufacturing facility cannot be used, the New York Times reports.

PLOS Papers on Frozen Shoulder GWAS, Epstein-Barr Effects on Immune Cell Epigenetics, More

In PLOS this week: genome-wide association study of frozen shoulder, epigenetic patterns of Epstein-Barr-infected B lymphocyte cells, and more.